ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
125.924,19
-1,12%
S&P 500
5.035,69
-1,57%
US Dollar vs BRL
5,1955
0,00%
Bitcoin
60.219,80
-0,63%
Brent Oil
85,60
-0,34%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. AbbVie Inc (ABBV)

  7. AbbVie Inc (ABBV) Notícias

ABBV AbbVie Inc

162,00
0,48 (0,30%)
30 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
AbbVie Inc ABBV NYSE Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,48 0,30% 162,00 19:47:17
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
161,07 159,69 163,05 162,64 161,52
mais cotações »

Notícias Recentes

Data Hora Fonte Título
26/04/202408:47IHMARKETNEWSU.S. Futures Climb in Pre-Market Trading Amid Tech Gains and..
26/04/202408:35PRNUSAbbVie Reports First-Quarter 2024 Financial Results
25/04/202409:00PRNUSNew Data Show RINVOQ® (upadacitinib) Demonstrated..
23/04/202409:00PRNUSAllergan Aesthetics Invites Consumers to Be the Face of..
18/04/202409:31PRNUSPhase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed..
12/04/202408:30PRNUSAbbVie Announces Late-Breaking Data at AAN Supporting..
09/04/202409:00PRNUSSkinMedica® Empowers Clear Skin Confidence with a New,..
04/04/202409:00PRNUSAbbVie to Host First-Quarter 2024 Earnings Conference Call
03/04/202409:30PRNUSAllergan Aesthetics Announces the Return of CoolMonth with..
01/04/202408:50GLOBENEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an..
26/03/202408:20IHMARKETNEWSSuper Micro Computer and Seagate Shares Surge on Analyst..
25/03/202412:00PRNUSAllergan Aesthetics Launches "Moving the Needle on Ethics"..
25/03/202409:31PRNUSAbbVie to Acquire Landos Biopharma, Further Strengthening..
25/03/202409:30GLOBEAbbVie to Acquire Landos Biopharma, Further Strengthening..
22/03/202416:02PRNUSU.S. Food and Drug Administration (FDA) Grants Full Approval..
21/03/202409:00PRNUSALLERGAN AESTHETICS CONTINUES TO CHAMPION INDIVIDUALITY,..
07/03/202410:00PRNUSAbbVie to Present at the Barclays 26th Annual Global..
06/03/202410:03PRNUSAbbVie and Allergan Aesthetics to Present New Data at 2024..
05/03/202414:09PRNCADragonfly a reçu un paiement d'étape à la suite de la prise..
05/03/202410:00PRNUSJUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA..
05/03/202409:00PRNUSDragonfly has Received Milestone Payment Following Dosing of..
28/02/202402:05PRNUSAbbVie and OSE Immunotherapeutics Announce Partnership to..
27/02/202410:00GLOBEHealis Therapeutics' asset CKDB-501A shares Phase III..
27/02/202409:45PRNUSU.S. Food and Drug Administration (FDA) Grants Priority..
22/02/202410:05PRNUSAbbVie and Tentarix Announce Collaboration to Develop..
21/02/202410:00PRNUSBOTOX® Cosmetic (onabotulinumtoxinA) Announces Its 2024..
20/02/202411:00PRNUSAbbVie Announces Appointment of Robert A. Michael as Chief..
19/02/202410:30PRNUSAbbVie Unveils New Data from Robust Gastroenterology..
15/02/202414:03PRNUSAbbVie Declares Quarterly Dividend
12/02/202409:37PRNUSAbbVie Completes Acquisition of ImmunoGen
08/02/202410:00PRNCAVYALEVMC (solution de foslévodopa/foscarbidopa), médicament..
06/02/202414:00PRNUSCalibr-Skaggs announces expansion of option and license..
02/02/202409:36PRNUSAbbVie Reports Full-Year and Fourth-Quarter 2023 Financial..
31/01/202413:00PRNUSAllergan Aesthetics Releases "Decoding the Future of..
25/01/202405:00PRNUSAllergan Aesthetics Showcases Commitment to Individuality,..
23/01/202410:00PRNUSAllē by Allergan Aesthetics is the Leading Aesthetics..
11/01/202408:18IHMARKETNEWSWall Street Highlights: Mastercard’s Financial Rise,..
09/01/202404:00PRNUSAbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for..
08/01/202411:16DJNAbbVie to Move Lutikizumab Into Phase 3 in Hidradenitis..
08/01/202410:05PRNUSLutikizumab Showed Positive Results in a Phase 2 Trial of..
04/01/202411:29DJNAbbVie, Umoja Biopharma Set CAR-T Cell Therapies..
04/01/202410:45PRNUSAbbVie and Umoja Biopharma Announce Strategic Collaboration..
04/01/202410:00PRNUSAbbVie to Host Full-Year and Fourth-Quarter 2023 Earnings..
03/01/202420:17DJNAbbvie Stock Edges Lower After CVS Says It Will Drop Humira..
03/01/202419:59DJNCVS Health To Cover Humira Biosimilars April 1
02/01/202410:00PRNUSAbbVie to Present at the 42nd Annual J.P. Morgan Healthcare..
13/12/202313:29DJNAbbVie Currently Up 11 Consecutive Days, on Pace for Longest..
12/12/202313:24DJNAbbVie Currently Up 10 Consecutive Days, on Pace for Longest..
12/12/202307:50IHMARKETNEWSHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic..
09/12/202314:00PRNUSNew Data for Bispecific Antibody Epcoritamab (DuoBody®..

Seu Histórico Recente

NYSE
ABBV
AbbVie
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados